Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
NCT ID:
NCT03574506
Eligibility Criteria:
Inclusion Criteria:
* All patients in the postpartum period (within 12 weeks of delivery) that were diagnosed with aHUS by their treating provider or who met standard diagnostic criteria.
* Subjects meeting diagnostic criteria for aHUS will be included in the study independent of the treatment approach employed by their providers.
* Those who received at least one dose of Eculizumab for treatment of suspected aHUS will be included, regardless of outcome.
Exclusion Criteria:
* Patients who did not authorize the use of their information after an informed consent process
* Patients who their physicians who did not agree to participate in or provide patient information.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
14 Years
Maximum Age:
49 Years
Study:
NCT03574506
Study Brief:
Protocol Section:
NCT03574506